Breast implants have been available for over 45 years and have withstood a test of time. Silicone breast implant safety has been a topic of discussion for many years. Just like every other medical specialty, the safety and efficacy of medical devices is always a top priority. Silicone breast implant safety had been evaluated through numerous studies over the years to best protect women interested in breast augmentation. Recently, The Food and Drug Administration’s (FDA) General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee conducted a hearing to evaluate the progress of silicone breast implants since improved silicone gel implants were reintroduced to the market in April of 2006. In conclusion, the safety and effectiveness of silicone breast implants was reconfirmed and it was determined that that there was no link between silicone breast implants and connective tissue disease. The FDA’s white paper reflected a high satisfaction level among women who had breast augmentation.
Manufacturers of the breast implants also indicated that the companies would seek out ways to improve study methodology and data collection to further support the validity of claims in the future. For example, Allergan breast implant recipients may participate in a study questionnaire online or by contacting Allergan on the phone. Mentor has made enhancements to the company’s web portal for improved ease of use.
If you have undergone the breast augmentation procedure, we encourage you to participate in follow up studies to continue to evaluate the safety and efficacy of breast implants over time. The results of these types of studies may be beneficial for you and other women who are interested in the breast augmentation procedure.
If you are interested in a plastic surgery, call board certified Dr. David Abramson, New York, New York plastic surgeon for a thorough consultation at 201-731-3134!